SCHEMBL8407112

SCHEMBL8407112

CC(C)(O)C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.69
CNR2 P34972 1/20 0.64
AR P10275 2/20 0.63
PGR P06401 1/20 0.63
CYP3A4 P08684 1/20 0.63
PDK1 Q15118 1/20 0.62
GRM4 Q14833 1/20 0.56
LMNA P02545 3/20 0.55
NPSR1 Q6W5P4 2/20 0.54
TRPV1 Q8NER1 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
MEN1 O00255 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
TMPRSS4 Q9NRS4 1/20 0.54
KCNJ5 P48544 1/20 0.54
KCNJ3 P48549 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1291336 0.89 KDR (0.71) KDRCNR2PDK1GRM4LMNA
SCHEMBL29625148 0.89 KDR (0.71) KDRCNR2PDK1GRM4LMNA
SCHEMBL29625146 0.89 KDR (0.71) KDRCNR2PDK1GRM4LMNA
SCHEMBL8409965 0.88 KDR (0.69) KDRCNR2PDK1GRM4LMNA
SCHEMBL31531550 0.87 KDR (0.64) KDRCNR2PDK1GRM4LMNA
SCHEMBL31495074 0.86 KDR (0.76) KDRCNR2PDK1GRM4LMNA
SCHEMBL12712751 0.85 AR (0.73) KDRCNR2ARPDK1LMNA
SCHEMBL3645017 0.84 KDR (0.73) KDRCNR2PDK1GRM4LMNA
SCHEMBL21654202 0.84 KDR (0.64) KDRCNR2PDK1GRM4LMNA
SCHEMBL4123404 0.83 AR (0.64) KDRCNR2ARPGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed